Retro Biosciences
Longevity-focused biotechnology company working to add 10 years to healthy human lifespan through three scientific approaches - cellular reprogramming, autophagy, and plasma-inspired therapeutics.
Website
https://retro.bioLocation
Redwood City, California, USA
Founded
2021
Categories
therapeutics, biotech, longevity-research, cellular-reprogramming, autophagy
Notes
Retro Biosciences is a longevity-focused biotechnology company with the ambitious goal of adding 10 years to healthy human lifespan. Founded in 2021, the company is headquartered in Redwood City, California.
The company pursues three main scientific approaches:
- Cellular Reprogramming: Rejuvenating cells to a more youthful state using partial reprogramming techniques
- Autophagy: Enhancing the cell's natural cleanup mechanisms to remove damaged components
- Plasma-Inspired Therapeutics: Developing therapies based on factors found in young blood that may have rejuvenating effects
Retro Biosciences received significant attention when Sam Altman (CEO of OpenAI) personally invested $180 million in the company in 2023, making it one of the most well-funded longevity startups.
Team
- Joe Betts-LaCroix - Co-founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/joebettslacroix
- Matt Buckley - Chief Operating Officer
- Sheng Ding, Ph.D. - Scientific Co-founder (Professor at UCSF)
Additional Research Findings
- $180 million investment from Sam Altman (2023)
- Three-pronged approach: reprogramming, autophagy, plasma therapeutics
- Goal: Add 10 years to healthy human lifespan
- CEO Joe Betts-LaCroix invested in VitaDAO
- Based in Redwood City, California
- One of the most well-funded longevity startups